Contact this trialFirst, we need to learn more about you.
Combination Drug
AD109 for Obstructive Sleep Apnea
Recruiting2 awardsPhase 3
Atlanta, Georgia
This trial is testing a new drug called AD109, which is a combination of aroxybutynin and atomoxetine, for treating obstructive sleep apnea (OSA). It is for
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service